Phanes: Phanes acquires second FDA orphan designation for bispecific antibody

Phanes: Phanes Therapeutics signs clinical supply agreement with Roche

Phanes: US FDA grants Fast Track designation to Phanes Therapeutics' PT217 to treat patients with extensivestage SCLC

Phanes: Phanes Therapeutics' PT886 granted Fast Track designation for the treatment of patients with metastatic claudin 18.2-positive pancreatic adenocarcinoma by the FDA

Press Release: Phanes : Phanes Therapeutics, Inc. announces granting of registered trademarks for its three proprietary technology platforms by the U.S. Patent and Trademark Office

Phanes: Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA (Pembrolizumab)

Press Release: Phanes : Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board